Biotech Values

[rkrw]

I think the uncertainty over Teva is the number one factor holding the stock back. Lawsuit number two. Skepticism over Copaxone factors in as well.

If Teva does get approved, I wouldn't look for them to discount all that much beyond Sandoz.